NPPB and differentiated thyroid carcinoma: A study shows that NT-proBNP levels increased in patients with differentiated thyroid carcinoma and is associated with an elevated risk of cardiovascular events [45].Furthermore, some studies discovered a potential value of NT-proBNP as biomarker for cardiovascular events in cancer during anticancer therapy [43].